Metadvice: The Venture Leader Medtech accelerating personalised and complex disease care

03.10.2024 10:00, Rita Longobardi

Meet André Jaun, Co-Founder of Metadvice. The Medtech startup's AI-powered software platform helps clinicians manage patients better and faster, enhancing preventative care and ensuring improved medical outcomes. In November, André and the other nine Swiss National Medtech Team members will fly to Boston on a business development and investor roadshow.

Name: André Jaun
Location: St-Sulpice (VD)
Nationality: Swiss
Graduated from: EPFL
Job title: Co-Founder & CTO
Number of employees: 19
Money raised: CHF 5M equity
First touchpoint with Venturelab: Venture Leaders Medtech 2024


Can you tell us who your product or solution helps, and how?
Clinicians need help to make complex decisions for chronic diseases based on an ever-increasing number of factors. Metadvice AI uses guidelines and real-world evidence (RWE) to manage comorbid patients holistically.

What market are you addressing and what is the potential of your startup in that market?
The product is scaling with soon 500’000 patients on the Metadvice platform and aiming to cover a majority of the 2000 Private Care Networks in the UK over the next couple of years. The potential for outcome-based medicine is even larger in the US, where HMOs aim for cost reductions in the long term.

---

How and where did you come up with the idea for your startup?
The advance of AI and the digitalization of medicine are a perfect fit that is bound to unlock value for multiple stakeholders (patients, payors, pharma) and the greater good of society. Meeting 2018 in Lausanne with my co-founders, Serge, Richard and I started with heme oncology in La Chaux-de-Fond, before switching to cardiovascular and auto-immune diseases in the UK.

What do you expect from the Venture Leaders Medtech roadshow, and how will it help you achieve your vision?
After working at scale with rather cheap healthcare (NHS primary care) and with smaller numbers in a more advanced setting (Innosuisse with Inselspital, Bern), Metadvice is ready to start competing in a rich and broad market such as the US.

What are your team’s key achievements to date?
I am proud of the science that crystallizes from our evidence-based precision medicine showing statistically significant digital twin cohorts bringing Popper’s empirical falsification principle literally to the doctors’ fingertip. Medicine is ripe for bias corrections (gender, ethnicity, cost) and helping to realise this is probably our highest achievement.

What is the most challenging and rewarding aspect of being a founder?
Multitasking. Starting the day writing an article, jumping between neural network optimization with an intern and regulatory compliance under MDR and finishing with pitching across the Atlantic… not to mention occasional job interviews somewhere in between!

What is the most important lesson you have learned as a founder?
Independence and resilience. Ideas are easy, and advice comes cheap, but limited resources for commercial implementation in a regulated landscape demand a lot of perseverance in front of occasional setbacks.

What is your favourite productivity hack/tool and why?
30 minutes to wait in front of a blank paper, forcing me to focus on what is important.

What was your dream job when you were a child?
Anything with experimentation, first with explosive effects and gradually in a more structured manner... but I believe in having been a scientist at heart from the start.